Page last updated: 2024-08-21

glycyrrhizic acid and Idiopathic Parkinson Disease

glycyrrhizic acid has been researched along with Idiopathic Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Gao, D; Gao, X; Jiang, X; Jin, M; Liu, K; Paudel, YN; Ren, Q; Shang, X; Sheng, W; Zhang, P; Zhang, X1
Angelopoulou, E; Papavassiliou, AG; Piperi, C1
Berg, D; Forrester, JV; Gasser, T; Hobert, MA; Maetzler, W; Martin, HL; Rattay, TW; Riedel, G; Santoro, M; Stathakos, P; Teismann, P; Tracey, KJ1

Reviews

1 review(s) available for glycyrrhizic acid and Idiopathic Parkinson Disease

ArticleYear
High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches.
    Journal of neurochemistry, 2018, Volume: 146, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antibodies; Glycyrrhizic Acid; HMGB1 Protein; Humans; Parkinson Disease

2018

Other Studies

2 other study(ies) available for glycyrrhizic acid and Idiopathic Parkinson Disease

ArticleYear
Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish.
    Journal of ethnopharmacology, 2022, Jun-28, Volume: 292

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Glycyrrhizic Acid; HMGB1 Protein; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotection; Neuroprotective Agents; Parkinson Disease; RNA, Messenger; Zebrafish

2022
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
    Neurobiology of disease, 2016, Volume: 91

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Female; Glycyrrhizic Acid; HMGB1 Protein; Humans; Male; Mice, Inbred C57BL; Microglia; Middle Aged; Neuroprotective Agents; Parkinson Disease; Tumor Necrosis Factor-alpha

2016